Filter by
Date
Cancer type
Cancer stage
Biomarker
Method of analysis
Selected categories
August, 2024
Identification of circulating tumor cells captured by the FDA-cleared Parsortix® PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations
ANGLE Europe Limited, Guildford, UK, University of Rochester, Rochester, US, and MD Anderson Cancer Center, Houston, US
August 2024
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland
July 2024
Combined microfluidic enrichment and staining workflow for single-cell analysis of circulating tumor cells in metastatic prostate cancer patients
Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
June, 2024
Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
March, 2024
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium
Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
January 2024
Prognostic significance of circulating tumor cells and tumor related transcripts in small cell lung cancer: A step further to clinical implementation
Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
1
23 ...
17